Detalhe da pesquisa
1.
The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
J Allergy Clin Immunol
; 152(2): 528-537, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587851
2.
[Apps in rheumatology : Is there a need for an app in therapy for axial spondyloarthritis?] / Apps in der Rheumatologie : Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
Z Rheumatol
; 82(3): 256-261, 2023 Apr.
Artigo
em Alemão
| MEDLINE | ID: mdl-34618212
3.
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age.
Clin Exp Rheumatol
; 40(9): 1657-1665, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874836
4.
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medication.
Rheumatol Int
; 42(8): 1373-1381, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694439
5.
Use of Complementary and Alternative Medicine in Patients with Primary Immunodeficiency: a Multicentric Analysis of 101 Patients.
J Clin Immunol
; 41(3): 585-594, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403468
6.
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial.
Rheumatology (Oxford)
; 60(1): 256-262, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32699904
7.
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
Rheumatology (Oxford)
; 60(11): 5318-5328, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738492
8.
ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis.
Clin Exp Rheumatol
; 39(2): 319-328, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32662413
9.
Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNFα inhibitors.
Rheumatol Int
; 41(11): 1979-1986, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991197
10.
Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test.
Clin Exp Rheumatol
; 38 Suppl 125(3): 59-64, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301433
11.
Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood.
Eur J Immunol
; 48(2): 366-379, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023682
12.
Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis.
Rheumatology (Oxford)
; 58(11): 2051-2060, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106368
13.
Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking.
Blood
; 129(1): 100-104, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784674
14.
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).
Clin Exp Rheumatol
; 37(6): 937-945, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025930
15.
Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.
Rheumatology (Oxford)
; 57(11): 1938-1946, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30010891
16.
Response to baricitinib based on prior biologic use in patients with refractory rheumatoid arthritis.
Rheumatology (Oxford)
; 57(5): 900-908, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29415145
17.
A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.
Ann Rheum Dis
; 76(9): 1598-1602, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28637670
18.
Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
Ann Rheum Dis
; 76(2): 399-407, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27323772
19.
Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
Ann Rheum Dis
; 75(1): 45-51, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25660991
20.
Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.
Ann Rheum Dis
; 75(9): 1637-44, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483255